Executive Medical Director, Clinical Development, Oncology Early Development

Executive Medical Director, Clinical Development -Oncology

Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC® Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC® targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. 

The company is progressing multiple investigational drugs through clinical development programs, including vepdegestrant, targeting the estrogen receptor for patients with locally advanced or metastatic ER+/HER2- breast cancer; ARV-102, targeting LRRK2 for neurodegenerative disorders; and ARV-393, targeting BCL6 for relapsed/refractory non-Hodgkin Lymphoma, and ARV-806, targeting KRAS driven cancers. 

In April 2024, Arvinas entered into a transaction with Novartis, including a global license agreement for the development and commercialization of the clinical stage PROTAC® androgen receptor protein degrader ARV-766 for the treatment of prostate cancer. The transaction closed in May 2024. 

#TeamArvinas is made up of passionate and curious employees, whose diverse thoughts and perspectives are highly valued. Arvinas employees embrace the freedom to pursue innovation, think creatively, and give back. They are driven by the company’s values and mission – to improve the lives of patients with serious diseases by pioneering therapies created with our revolutionary PROTAC® protein degradation platform. We’re really excited about the work we’re doing inside and outside of Arvinas, and think you will be, too. But don’t just take our word for it – learn more about life at Arvinas and what employees have to say.  

 

 

Position Summary

Arvinas is looking for an experienced Executive Medical Director with the passion and creativity to develop great medicines for oncology patients. The ideal candidate is a physician with experience of global drug development early to late phase programs and, who is enthusiastic about applying their knowledge to the cause of patients around the globe who have no approved therapies for their disease. The individual will be a self-starter with excellent management and leadership capabilities who is seeking to lead and be part of an innovative team that will drive the drug development processes from start to finish.

Reporting into the Vice President of Clinical Research, the Executive Medical Director will be primarily responsible for the strategy, development and execution of clinical research and development programs, including the clinical leadership of the pivotal trials and regulatory filing activities. This position will serve as a key liaison between company and clinical investigators and establish credible relationships with opinion leaders, regulatory officials and other key stakeholders and partners. The successful candidate will be ready for a career defining experience and have the passion to drive a number of therapeutics for serious debilitating diseases to final approval.

This role can be located at our headquarters in New Haven, CT or work with a hybrid or remote work arrangement from a location within the U.S.

 

Principal Responsibilities

Key responsibilities of this role include, but are not limited to:

• Partner with discovery and biology leadership and provide clinical input and guidance to develop the oncology corporate strategy.
• Responsible for trial design of Phase I/II/III research trials requiring expertise and stewardship in the areas of oncology/hematology
• Directly supervise and monitor trial conduct.

• Work closely with all functions of the organization and external partners to manage trial execution and investigators’ engagement.
• Collaborate in developing global regulatory plans and play a key role in regulatory meetings in partnership with regulatory affairs. Identify opportunities for external collaboration.
• Follow important developments and relevant trends in scientific literature and develop/maintain contacts with external